Lippis Daniel J.

CVP, TAVR

Lippis Daniel J. has filed 17 SEC Form 4 filings (37 transaction rows) across 1 company, with disclosures dating back to 2025. 17 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.

On the most recent filing, Lippis Daniel J. is listed as CVP, TAVR at Edwards Lifesciences Corp. Inside the rolling window, Lippis Daniel J. reported no open-market purchases and 13 open-market sales totaling $925K in EW. The largest disclosed transaction in the window is a sale of 1,019 EW shares on Jan 9, 2026, worth $87K.

Companies traded

Other insiders at EW

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$925K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EWSale$53KOct 8SEC ↗
EWSale$54KSep 11SEC ↗
EWSale$57KAug 11SEC ↗
EWSale$57KJul 10SEC ↗
EWSale$57KJul 1SEC ↗
EWSale$50KMay 18SEC ↗
EWSale$85KMay 4SEC ↗
EWSale$86KMay 4SEC ↗
EWSale$83KApr 6SEC ↗
EWSale$87KMar 11SEC ↗
EWSale$87KJan 9SEC ↗
EWSale$86KDec 12SEC ↗
EWSale$84KNov 10SEC ↗
Showing 1–13 of 13
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Lippis Daniel J. made?

Lippis Daniel J. has filed 17 SEC Form 4 filings (37 transaction rows) across 1 company since 2025.

Which companies does Lippis Daniel J. trade?

Lippis Daniel J. has filed SEC Form 4 disclosures for 1 company, including EW.

When was Lippis Daniel J.'s most recent SEC Form 4 filing?

Lippis Daniel J.'s most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.

What is Lippis Daniel J.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Lippis Daniel J. is listed as CVP, TAVR.

What is Lippis Daniel J.'s total buy and sell value in the current window?

Inside the rolling retention window, Lippis Daniel J. bought $0 and sold $925K based on SEC Form 4 filings.

What was Lippis Daniel J.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,019 EW shares on 2026-01-09, worth $87K, per SEC Form 4 filings.